Edwards Lifesciences praises CMS NCD on transcatheter aortic valve replacement

RegulatoryPositive

AI Analysis

Summary

Edwards Lifesciences issued a statement praising a CMS National Coverage Determination on transcatheter aortic valve replacement. Limited details provided on the specific outcome or impact.

Importance:3/10

Sentiment:

0.50

CMSNCDregulatorytranscatheter aortic valve replacementreimbursement

Related Companies

$EW

Read the original article

Published by Seeking Alpha Healthcare on September 10, 2026 10:33 PM

Read Original